BioCentury
ARTICLE | Clinical News

Ostex regulatory update

February 16, 1999 8:00 AM UTC

The FDA granted marketing approval for OSTX's Osteomark NTx Serum test to detect crosslinked N-telopeptides of type I collagen (NTx) in serum as a marker for bone resorption. The company also market...